Alternative Dosing and Regimen of Replagal to Treat Fabry Disease - Related Studies

Alternative Dosing and Regimen of Replagal to Treat Fabry Disease

This study has been completed.

Study NCT00075244. Last updated on March 3, 2008. Information provided by National Institutes of Health Clinical Center (CC)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Fabry Disease

2	More general conditions related to this trial
		Brain Diseases
		Brain Diseases, Metabolic
		Brain Diseases, Metabolic, Inborn
		Central Nervous System Diseases
		Genetic Diseases, Inborn
		Genetic Diseases, X-Linked
		Lipid Metabolism Disorders
		Lipid Metabolism, Inborn Errors
		Lipidoses
		Lysosomal Storage Diseases
		Lysosomal Storage Diseases, Nervous System
		Metabolic Diseases
		Metabolism, Inborn Errors
		Nervous System Diseases
		Sphingolipidoses

3	Interventions listed in this trial
		Replagal

4	Sponsors listed in this trial
		National Institute of Neurological Disorders and Stroke (NINDS)